Hayek Kallen Investment Management’s CVS Health CVS Stock Holding History

Hayek Kallen Investment Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,056	Closed	-$343K	–	96
2025 Q1	$343K	Sell	5,056 -1,766	-26%	-$106K	0.13%	75
2024 Q4	$306K	Sell	6,822 -12,484	-65%	-$700K	0.11%	79
2024 Q3	$1.21M	Sell	19,306 -116	-0.6%	-$6.77K	0.43%	48
2024 Q2	$1.15M	Sell	19,422 -201	-1%	-$12.6K	0.43%	45
2024 Q1	$1.56M	Sell	19,623 -43	-0.2%	-$3.29K	0.6%	43
2023 Q4	$1.55M	Sell	19,666 -243	-1%	-$17.3K	0.65%	43
2023 Q3	$1.39M	Sell	19,909 -1,090	-5%	-$77.2K	0.62%	43
2023 Q2	$1.45M	Buy	20,999 +10	+0%	+$712	0.62%	43
2023 Q1	$1.56M	Sell	20,989 -1,492	-7%	-$125K	0.71%	41
2022 Q4	$2.1M	Sell	22,481 -74	-0.3%	-$7.14K	0.97%	35
2022 Q3	$2.15M	Sell	22,555 -313	-1%	-$31K	1.01%	34
2022 Q2	$2.12M	Sell	22,868 -144	-0.6%	-$14.1K	0.92%	35
2022 Q1	$2.33M	Sell	23,012 -69	-0.3%	-$7.25K	0.86%	36
2021 Q4	$2.38M	Buy	23,081 +6	+0%	+$554	0.85%	35
2021 Q3	$1.96M	Sell	23,075 -229	-1%	-$19.2K	0.89%	37
2021 Q2	$1.94M	Sell	23,304 -166	-0.7%	-$13.6K	0.82%	40
2021 Q1	$1.77M	Buy	23,470 +10	+0%	+$728	0.8%	43
2020 Q4	$1.6M	Buy	23,460 +461	+2%	+$30K	0.77%	41
2020 Q3	$1.34M	Sell	22,999 -919	-4%	-$57.2K	0.75%	38
2020 Q2	$1.55M	Buy	23,918 +2,021	+9%	+$127K	0.88%	39
2020 Q1	$1.3M	Sell	21,897 -381	-2%	-$25.4K	0.87%	40
2019 Q4	$1.66M	Buy	22,278 +789	+4%	+$55.4K	0.96%	38
2019 Q3	$1.35M	Buy	21,489 +1,630	+8%	+$96.6K	0.85%	39
2019 Q2	$1.08M	Buy	19,859 +7,109	+56%	+$383K	0.69%	44
2019 Q1	$688K	Sell	12,750 -41	-0.3%	-$2.53K	0.45%	46
2018 Q4	$838K	Buy	12,791 +7	+0.1%	+$523	0.6%	41
2018 Q3	$1.01M	Sell	12,784 -142	-1%	-$10.2K	0.64%	41
2018 Q2	$832K	Sell	12,926 -641	-5%	-$42.2K	0.57%	42
2018 Q1	$844K	Sell	13,567 -768	-5%	-$55.1K	0.59%	41
2017 Q4	$1.04M	Sell	14,335 -218	-1%	-$15.8K	0.68%	38
2017 Q3	$1.18M	Sell	14,553 -593	-4%	-$46.9K	0.81%	38
2017 Q2	$1.22M	Buy	15,146 +721	+5%	+$56.9K	0.82%	40
2017 Q1	$1.13M	Buy	14,425 +882	+7%	+$70.4K	0.78%	39
2016 Q4	$1.07M	Buy	13,543 +1,279	+10%	+$103K	0.78%	38
2016 Q3	$1.09M	Buy	12,264 +2,904	+31%	+$274K	0.78%	37
2016 Q2	$896K	Sell	9,360 -246	-3%	-$24.5K	0.64%	38
2016 Q1	$996K	Sell	9,606 -47	-0.5%	-$4.57K	0.74%	38
2015 Q4	$944K	Sell	9,653 -48	-0.5%	-$4.7K	0.72%	39
2015 Q3	$936K	Sell	9,701 -898	-8%	-$94.4K	0.73%	39
2015 Q2	$1.11M	Sell	10,599 -1,023	-9%	-$105K	0.83%	38
2015 Q1	$1.2M	Buy	11,622 +2	+0%	+$202	0.88%	37
2014 Q4	$1.12M	Sell	11,620 -49	-0.4%	-$4.32K	0.83%	38
2014 Q3	$929K	Sell	11,669 -298	-2%	-$23.5K	0.71%	38
2014 Q2	$902K	Buy	11,967 +252	+2%	+$19K	0.68%	38
2014 Q1	$877K	Sell	11,715 -123	-1%	-$8.69K	0.7%	39
2013 Q4	$847K	Sell	11,838 -304	-3%	-$19.5K	0.66%	40
2013 Q3	$689K	Sell	12,142 -298	-2%	-$17.8K	0.57%	42
2013 Q2	$711K	Buy	+12,440	New	+$721K	0.6%	41

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hayek Kallen Investment Management's CVS Position: Q2 2025 in Review

Hayek Kallen Investment Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 5,056 shares — an estimated $343K sold.

Hayek Kallen Investment Management first reported a position in CVS in Q2 2013 and held it in 48 quarters. The position peaked at $2.38M in Q4 2021. 1,759 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Hayek Kallen Investment Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Hayek Kallen Investment Management sold 5,056 CVS Health shares in Q2 2025, an estimated $343K.
Hayek Kallen Investment Management first reported a position in CVS Health in Q2 2013 and held it in 48 quarters.
Hayek Kallen Investment Management's CVS Health position peaked at $2.38M in Q4 2021.
1,759 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Hayek Kallen Investment Management's 13F filing for Q2 2025, filed 15 Aug 2025.